We’re pleased to share that our Hangzhou, China facility has successfully completed an audit with the independent supply chain consortium, Rx-360.
With a focus on building strong partnerships between pharmaceutical manufacturers and suppliers, Rx-360 helps to ensure the integrity of supply chains through member-led working groups and their joint audit program. What makes this exciting is that many of Entegris’ customers who manufacture lifesaving therapeutics are also Rx-360 members. This provides easy ways to access the tools they need to qualify and validate their partners, suppliers, and customers to ensure patient safety.
Rx-360 Streamlines the Supplier Audit Process
Supplier audits are essential tools used to establish a safe and reliable supply chain. A supplier audit typically involves one or two auditors spending two or three days at a supplier’s site. During this time, they dig into all aspects of supplier’s manufacturing and supply chain operations, from processes and equipment to training and paperwork. These holistic audits are often a time-consuming and expensive activity for both parties involved. As such, audits are often a major barrier to adopting new suppliers.
Rx-360 conducts independent audits of suppliers to the biopharma industry, similar in scope and scrutiny to a pharmaceutical customer. These audit results are then made available to help alleviate the audit burden. This unlocks an easier transition to new materials and increased access to process expertise available from diverse suppliers.
Certifying Entegris as a Leading Pharmaceutical Supplier
The completion of the site audit with no major findings is a key validation of the new Entegris PharmsteriTM filter manufacturing supply chain. As a new entrant to the market, this important milestone demonstrates that our facility and quality systems are among the best in the industry.
Only the highest quality suppliers to the pharmaceutical market have Rx-360 reports available for examination. By making our audit report available to potential customers, we demonstrate that Entegris filtration solutions are among the highest performing and most reliable options available in a variety of markets. We also demonstrate that we can solve the full range of contamination control challenges.
The completion of this audit is a result of the extensive resources that have been deployed to establish the Hangzhou site as a premier life sciences manufacturing facility. Development of the global supply chain and preparation for the audit required extensive cross-functional support from the Entegris Hangzhou team as well as members from our Taiwanese and U.S. teams and demonstrates our continuing commitment to understanding and meeting customer needs globally.
Want to learn more? Visit our filtration resource page.
